Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004685 |
---|---|
Receipt number | R000005568 |
Scientific Title | Phase II study of Combination Therapy of Pemetrexed/Carboplatin/Bevacizumab for Advanced Non-small-cell lung cancer |
Date of disclosure of the study information | 2010/12/09 |
Last modified on | 2019/02/16 15:38:03 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/12/08 13:07:31 | ||
2 | Update | 2012/06/16 10:23:34 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2012/06/16 10:26:10 | Last follow-up date |
|
4 | Update | 2019/02/16 15:38:03 | Anticipated trial start date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results |